Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial.

ABSTRACT:

SUBMITTER: Hemmerling A 

PROVIDER: S-EPMC12173475 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature